Investor Enthusiasm Spikes As ARCA Biopharma (ABIO) Announces Merger Plans

The current trading session witnesses a remarkable surge in the value of ARCA Biopharma, Inc. (NASDAQ: ABIO) stock, marking a notable increase of 104.09% to $3.49 as per the latest check. This upward trajectory in ABIO stock follows the announcement of a merger agreement. A final agreement has been reached between ARCA Biopharma (ABIO) and […]